To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

Bill: 115-hr-4392
Sponsor: full_name: Rep. McKinley, David B. [R-WV-1]
Introduced: 2017-11-14
Policy area: Health
Subjects: Administrative law and regulatory procedures

Department of Health and Human Services

Health care costs and insurance

Home and outpatient care

Hospital care

Inflation and prices

Medicare

Prescription drugs
Latest action: action_date: 2017-11-17
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2017-11-14
action_desc: Introduced in House
text: <p>This bill nullifies&nbsp;a rule finalized by the&nbsp;Centers for Medicare &amp; Medicaid&nbsp;Services on November 13, 2017,&nbsp;that modifies payment under Medicare for certain drugs purchased&nbsp;through the 340B discount program.</p>

tv_txt: I 115th CONGRESS 1st Session H. R. 4392 IN THE HOUSE OF REPRESENTATIVES November 14, 2017 Mr. McKinley (for himself, Mr. Thompson of California , Mr. Johnson of Ohio , Mr. Kustoff of Tennessee , Mr. Courtney , and Ms. Castor of Florida ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

1. Treatment of certain Medicare hospital outpatient payments for certain drugs; OPPS budget neutrality adjustment (a) Preventing implementation of Medicare hospital outpatient payment changes for hospitals that purchase drugs under 340B drug discount program Beginning on the date of the enactment of this Act, the Secretary of Health and Human Services shall not take any action to implement, administer, or enforce the provision of the final regulation titled the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs published on November 13, 2017 (82 Fed. Reg. 52356 et seq.), that would change the payment amount under the Prospective Payment System for Hospital Outpatient Department Services under section 1833(t) of the Social Security Act ( 42 U.S.C. 1395l(t) ) for separately payable, nonpass-through drugs and biologicals purchased under the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ). The payment amount under such payment system under such section 1833(t) for such a drug or biological shall be determined through the same methodology as if such final regulation did not apply. (b) OPPS budget neutrality adjustment The first sentence of section 1833(t)(9)(B) of the Social Security Act ( 42 U.S.C. 1395l(t)(9)(B) ) is amended by striking part each place such term appears and inserting subsection each such place.